Answers are grounded in this paper and cite their sources.
Neither the rate of administration nor the sodium chloride content of intravenous fluids significantly influenced neurologic outcomes in children with diabetic ketoacidosis. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Health Resources and Services Administration; PECARN DKA FLUID ClinicalTrials.gov number, NCT00629707 .).
No takes yet. Share an insight, caveat, or question.
Kuppermann et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: